The use of OCT in good visual acuity MOGAD and AQP4-NMOSD patients; with and without optic neuritis.
Mult Scler J Exp Transl Clin
; 7(4): 20552173211066446, 2021 Oct.
Article
em En
| MEDLINE
| ID: mdl-35035989
ABSTRACT
Myelin oligodendrocyte-antibody-associated disease (MOGAD) often presents with severe optic neuritis (ON) but tends to recover better than in aquaporin-4 antibody neuromyelitis optica spectrum disorder (AQP4-NMOSD). We measured OCT and VEP in MOGAD and AQP4-NMOSD eyes with good visual function, with or without previous ON episodes. Surprisingly, OCT and/or VEPs were abnormal in 84% MOGAD-ON versus 38% AQP4-NMOSD-ON eyes (p = 0.009) with good vision, compared with 18% and 17% respectively of eyes with no previous ON. A sub-group with macular OCT performed as part of a research study confirmed both retinal and macular defects in visually-recovered MOGAD eyes. These findings have implications for investigation and management of MOGAD patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Mult Scler J Exp Transl Clin
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Reino Unido